Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

MTFB

Motif Bio (MTFB)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
06/10/201710:54Alliance NewsAlliance NewsMotif Bio Receives Positive Pre-Clinical Data For Iclaprim DrugLSE:MTFBMotif Bio Plc
06/10/201708:00RNS Non-RegulatoryMotif Bio PLC New Pre-Clinical Data for Iclaprim at IDWeek 2017LSE:MTFBMotif Bio Plc
05/10/201710:57UK RegulatoryMotif Bio PLC Holding(s) in CompanyLSE:MTFBMotif Bio Plc
04/10/201709:31Alliance NewsAlliance NewsMotif Bio Shares Jump On Positive Late-Stage Iclaprim Study ResultsLSE:MTFBMotif Bio Plc
04/10/201708:00UK RegulatoryMotif Bio PLC Positive Topline Results in Phase Three StudyLSE:MTFBMotif Bio Plc
29/09/201713:22Alliance NewsAlliance NewsMotif Bio On Track For Strategic Goals As Interim Loss WidensLSE:MTFBMotif Bio Plc
29/09/201708:02UK RegulatoryMotif Bio PLC Half-year ReportLSE:MTFBMotif Bio Plc
25/09/201711:42Alliance NewsAlliance NewsAmphion Innovations Sells 4.4 Million Shares In Motif Bio In Loan Deal (ALLISS)LSE:MTFBMotif Bio Plc
15/09/201715:21Alliance NewsAlliance NewsMotif Bio's Iclaprim Gets Orphan Drug Status For Lung InfectionsLSE:MTFBMotif Bio Plc
15/09/201715:07UK RegulatoryMotif Bio PLC iclaprim granted Orphan Drug Designation by US FDALSE:MTFBMotif Bio Plc
08/09/201714:00RNS Non-RegulatoryMotif Bio PLC Host Investor and Analyst Event on September 20LSE:MTFBMotif Bio Plc
31/08/201714:00RNS Non-RegulatoryMotif Bio PLC Company to present at conferences in SeptemberLSE:MTFBMotif Bio Plc
09/08/201712:12Alliance NewsAlliance NewsMotif Bio Completes Treatment Phase Of Second Phase III Iclaprim TrialLSE:MTFBMotif Bio Plc
09/08/201708:00UK RegulatoryMotif Bio PLC REVIVE 2 Trial Last Patient TreatedLSE:MTFBMotif Bio Plc
18/07/201713:38Alliance NewsAlliance NewsMotif Bio Increases Consultancy Fee For Amphion Innovations EmployeeLSE:MTFBMotif Bio Plc
18/07/201708:00UK RegulatoryMotif Bio PLC Amendment to Amphion Consultancy AgreementLSE:MTFBMotif Bio Plc
06/07/201708:00RNS Non-RegulatoryMotif Bio PLC PRESENTING THREE POSTERS ON ICLAPRIM AT ID WEEKLSE:MTFBMotif Bio Plc
28/06/201713:41UK RegulatoryMotif Bio PLC Exercise of warrantsLSE:MTFBMotif Bio Plc
22/06/201716:20UK RegulatoryMotif Bio PLC Result of General MeetingLSE:MTFBMotif Bio Plc
22/06/201708:00RNS Non-RegulatoryMotif Bio PLC Presents at ID Week 2017LSE:MTFBMotif Bio Plc
15/06/201718:42UK RegulatoryMotif Bio PLC Results of Annual General MeetingLSE:MTFBMotif Bio Plc
14/06/201708:01RNS Non-RegulatoryMotif Bio PLC Presentation at BIO International ConventionLSE:MTFBMotif Bio Plc
05/06/201719:20UK RegulatoryMotif Bio PLC Publication of Shareholder CircularLSE:MTFBMotif Bio Plc
02/06/201717:48Alliance NewsAlliance NewsUPDATE: Motif Bio Raises GBP20 Million In Share Placing (ALLISS)LSE:MTFBMotif Bio Plc
02/06/201717:36UK RegulatoryMotif Bio PLC Result of PlacingLSE:MTFBMotif Bio Plc
02/06/201710:25Alliance NewsAlliance NewsMotif Bio To Raise GBP19 Million In Placing For Iclaprim Development (ALLISS)LSE:MTFBMotif Bio Plc
02/06/201708:00UK RegulatoryMotif Bio PLC Proposed PlacingLSE:MTFBMotif Bio Plc
23/05/201717:40UK RegulatoryMotif Bio PLC Second Price Monitoring ExtnLSE:MTFBMotif Bio Plc
23/05/201717:35UK RegulatoryMotif Bio PLC Price Monitoring ExtensionLSE:MTFBMotif Bio Plc
18/05/201708:01UK RegulatoryMotif Bio PLC Publication of UK Annual Report and AccountsLSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network